Tonkin AM - Search Results

1

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.

Boekholdt SM, Arsenault BJ, Hovingh GK, Mora S, Pedersen TR, Larosa JC, Welch KM, Amarenco P, Demicco DA, Tonkin AM, Sullivan DR, Kirby A, Colhoun HM, Hitman GA, Betteridge DJ, Durrington PN, Clearfield MB, Downs JR, Gotto AM Jr, Ridker PM, Kastelein JJ. Boekholdt SM, et al. Among authors: tonkin am. Circulation. 2013 Oct 1;128(14):1504-12. doi: 10.1161/CIRCULATIONAHA.113.002670. Epub 2013 Aug 21. Circulation. 2013. PMID: 23965489 Free PMC article.

2

Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?

Simes RJ, Marschner IC, Hunt D, Colquhoun D, Sullivan D, Stewart RA, Hague W, Keech A, Thompson P, White H, Shaw J, Tonkin A; LIPID Study Investigators. Simes RJ, et al. Circulation. 2002 Mar 12;105(10):1162-9. doi: 10.1161/hc1002.105136. Circulation. 2002. PMID: 11889008

3

Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.

Sacks FM, Tonkin AM, Craven T, Pfeffer MA, Shepherd J, Keech A, Furberg CD, Braunwald E. Sacks FM, et al. Among authors: tonkin am. Circulation. 2002 Mar 26;105(12):1424-8. doi: 10.1161/01.cir.0000012918.84068.43. Circulation. 2002. PMID: 11914249 Clinical Trial.

4

Safety and tolerability of pravastatin in long-term clinical trials: prospective Pravastatin Pooling (PPP) Project.

Pfeffer MA, Keech A, Sacks FM, Cobbe SM, Tonkin A, Byington RP, Davis BR, Friedman CP, Braunwald E. Pfeffer MA, et al. Circulation. 2002 May 21;105(20):2341-6. doi: 10.1161/01.cir.0000017634.00171.24. Circulation. 2002. PMID: 12021218

5

Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?

Glasziou PP, Eckermann SD, Mulray SE, Simes RJ, Martin AJ, Kirby AC, Hall JP, Caleo S, White HD, Tonkin AM. Glasziou PP, et al. Among authors: tonkin am. Med J Aust. 2002 Oct 21;177(8):428-34. doi: 10.5694/j.1326-5377.2002.tb04883.x. Med J Aust. 2002. PMID: 12381252

6

Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin.

West MJ, White HD, Simes RJ, Kirby A, Watson JD, Anderson NE, Hankey GJ, Wonders S, Hunt D, Tonkin AM. West MJ, et al. Among authors: tonkin am. J Hypertens. 2002 Dec;20(12):2513-7. doi: 10.1097/00004872-200212000-00032. J Hypertens. 2002. PMID: 12473877 Clinical Trial.

7

Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.

Hague W, Forder P, Simes J, Hunt D, Tonkin A; LIPID Investigators. Hague W, et al. Am Heart J. 2003 Apr;145(4):643-51. doi: 10.1067/mhj.2003.1. Am Heart J. 2003. PMID: 12679760 Clinical Trial.

8

Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial.

Keech A, Colquhoun D, Best J, Kirby A, Simes RJ, Hunt D, Hague W, Beller E, Arulchelvam M, Baker J, Tonkin A; LIPID Study Group. Keech A, et al. Diabetes Care. 2003 Oct;26(10):2713-21. doi: 10.2337/diacare.26.10.2713. Diabetes Care. 2003. PMID: 14514569 Clinical Trial.

9

Accuracy of the Australian National Death Index: comparison with adjudicated fatal outcomes among Australian participants in the Long-term Intervention with Pravastatin in Ischaemic Disease (LIPID) study.

Magliano D, Liew D, Pater H, Kirby A, Hunt D, Simes J, Sundararajan V, Tonkin A. Magliano D, et al. Aust N Z J Public Health. 2003 Dec;27(6):649-53. doi: 10.1111/j.1467-842x.2003.tb00615.x. Aust N Z J Public Health. 2003. PMID: 14723416 Free article.

10

Statins for stroke prevention: disappointment and hope.

Amarenco P, Tonkin AM. Amarenco P, et al. Among authors: tonkin am. Circulation. 2004 Jun 15;109(23 Suppl 1):III44-9. doi: 10.1161/01.CIR.0000131518.25959.8F. Circulation. 2004. PMID: 15198966 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

368 results

Search Page